Tianjin Tianyao Pharmaceuticals Co., Ltd. Class ASSE: 600488

Announcement on the 2025 Evaluation Report on ""Corporate Value and Return Enhancement"" and 2026 Action Plan

· Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the 2025 Evaluation Report on ""Corporate Value and Return Enhancement"" and 2026 Action Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment